Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

2Total
Not Applicable (2)

Trial Status

Not Yet Recruiting3
Enrolling By Invitation1

Clinical Trials (4)

Showing 4 of 4 trials
NCT07495644Not Yet RecruitingPrimary

Efficacy of Different Biological Treatments in Patients With Inflammatory Bowel Disease After One Year of Treatment in Upper Egypt

NCT07484620Not ApplicableNot Yet RecruitingPrimary

Physical Activity and Fitness in Pediatric Inflammatory Bowel Disease

NCT07347158Not ApplicableEnrolling By Invitation

Effectiveness of Health Education as a Nursing Intervention in Improving Quality of Life and Reducing Symptoms of Anxiety and Depression in Ostomy Patients Following Digestive Surgery: A Quasi-Experimental Study.

NCT07184138Not Yet RecruitingPrimary

Real-World Study on the Safety and Effectiveness of IL-23 Inhibitors for Inflammatory Bowel Disease in China

Showing all 4 trials

Research Network

Activity Timeline